NQO1 and cholangiocarcinoma: Moreover, the activity of NAD(P)H:quinone oxidoreductase-1 (NQO1), a xenobiotic-metabolizing and antioxidant enzyme, is suppressed by inflammatory cytokines in cholangiocarcinoma cells, with the consequent increase in NO production and oxidative stress [117].